Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
- PMID: 33996790
- PMCID: PMC8113756
- DOI: 10.3389/fcell.2021.627816
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
Abstract
Research with induced pluripotent stem cells (iPSCs) involves specific ethical challenges, which should be addressed in the informed consent process. Up to now, little concern has been paid to the practice of information in iPSC-clinical studies. In order to fill this research gap, we have searched the documentation of the Research Ethics Committee at Ulm University from the years 2007 to 2019. In our previous research, we have identified 11 items for evaluation of the process of information in iPSC research. We used these items to analyze content and form of information provided for participants in the iPSC studies conducted at Ulm University and Ulm University Hospital in Germany. All analyzed studies provide general information regarding the study's aim, method, and collection of donor's personal data and specimen. The information for participants in these studies adheres to general guidelines for research involving human subjects; however, in several areas fails to take into account the specific nature of research with iPSCs. The majority of analyzed studies fail to provide information about possible individual consequences connected with genetic research, such as the possibility of re-identification of the donor or incidental findings acquired during research. Missing is also information about the possibility of future studies involving reproductive research or transplantation of cells and organs. The donor information process in all analyzed studies is conducted in form of the information sheet and oral information. The results of our research show that the process of informed consent in iPSC research should be updated as new developments emerge in this area. However, comprehension of information should not be jeopardized through information overload. Effective communication of essential information requires improved information methods tailored to the needs of participants, such as video animations, interactive consent modules or social media instruments.
Keywords: clinical research; clinical translation; ethics; induced pluripotent stem cells; informed consent.
Copyright © 2021 Orzechowski, Schochow, Kühl and Steger.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs).Stem Cell Res Ther. 2020 Mar 19;11(1):126. doi: 10.1186/s13287-020-01644-4. Stem Cell Res Ther. 2020. PMID: 32192531 Free PMC article. Review.
-
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.Stem Cells Transl Med. 2012 May;1(5):409-21. doi: 10.5966/sctm.2012-0029. Epub 2012 May 8. Stem Cells Transl Med. 2012. PMID: 23197820 Free PMC article.
-
The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):82-94. doi: 10.11124/jbisrir-2015-2304. JBI Database System Rev Implement Rep. 2015. PMID: 26571285
-
Participant understanding and recall of informed consent for induced pluripotent stem cell biobanking.Cell Tissue Bank. 2016 Sep;17(3):449-56. doi: 10.1007/s10561-016-9563-8. Epub 2016 Jun 14. Cell Tissue Bank. 2016. PMID: 27299783
-
Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.Front Cardiovasc Med. 2018 Jan 25;5:4. doi: 10.3389/fcvm.2018.00004. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29423397 Free PMC article. Review.
Cited by
-
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0. Mol Cancer. 2023. PMID: 38017433 Free PMC article. Review.
References
-
- Blau H. M., Daley G. Q. (2019). Stem cells in the treatment of disease. N. Engl. J. Med. 380 1748–1760. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous